Who invested in Connect Biopharmaceuticals

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$75Mraised across 2 rounds since 2017, from 2 sources

$20MSeries A$55MSeries B

Latest round: Series B, $55MJan 2019
Step-upi: 2.8×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201720182019

$20MSeries A$55MSeries B

First round: Series A, $20M
Biggest round: $55M
Between rounds: 23 months

The rounds

Jan 2019
Series B$55M1 new
- Advantech Capital
Reported by China Money Network
Jan 2017
Series A$20M2 new
- Cowin Capital
- Lapam Capital
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2017Series B2019

Cowin CapitalAdvantech CapitalLapam Capital

Everyone who backed them

Cowin CapitalVC firm1round

Advantech CapitalPrivate equity1round

Lapam CapitalInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Connect Biopharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.